Authors



Brian Mullin, Brand Insights Contributor, Mgr. of Clinical Project Svcs, Almac Clinical Technologies

Latest:

IRT: A Competitive Advantage to Accelerate Clinical Trials

Interactive response technology (IRT) can serve many different functions in clinical research, from patient randomization to making data-driven calculations for patient dosing.


Steve McDonald, Brand Insights Contributor, Dir. of Business Dev, Almac Clinical Technologies

Latest:

IRT: A Competitive Advantage to Accelerate Clinical Trials

Interactive response technology (IRT) can serve many different functions in clinical research, from patient randomization to making data-driven calculations for patient dosing.



Chartfield Bliss

Latest:

3 Ways CTMS Helps Manage Adaptive Trials

While adaptive trial designs have been slow to gain traction, there a many benefits to adopting this trial model.


John Benbrook

Latest:

Todos Juntos por la Salud

A MMG strategic initaitve to address disparities in clinical research participation among Hispanic and Latino communities.


Elligo

Latest:

Planning Clinical Research Studies for Successful Decentralized Trials

This podcast will discuss: • How partnering with specialized research organizations can help identify large, diverse patient populations to facilitate clinical studies designed around the patient • How advanced study planning and communication with regulators can ensure more successful execution of decentralized and hybrid clinical trials • The importance of the patient-physician dyad in implementing successful research studies


Herbert Maier-Lenz, MD

Latest:

Academic Strength in Germany

The founding of the KKSN has helped Germany increase its clinical trial output.


Dr. Satish Tadikonda

Latest:

New Technologies to Improve Clinical Information Management

Today's pharmaceutical industry faces many challenges as drug development costs continue to climb, pricing pressures mount, and new global markets gain critical importance.


Jean Pierre Wery

Latest:

Analyzing 2013 Oncology Trends to Predict 2014 Directions

When examining the frequency in use of keywords related to cancer research, some important trends emerge.


Esther Daemen, MBA, RN

Latest:

Moving From Compliance to Competency: A Harmonized Core Competency Framework for the Clinical Research Professional

Medicines development and clinical research are among the most heavily regulated activities on a global basis.


Kimberly Irvine, CIP, CIM

Latest:

Playing in the Sandbox--How Local Institutional Review Boards Can Happily Co-Exist with Central IRBs

A recent paper published in PLOS ONE addresses research institutions? willingness ?or lack thereof?to defer to central institutional review boards for multicenter clinical trials.


Rebecca Li, PhD

Latest:

Moving From Compliance to Competency: A Harmonized Core Competency Framework for the Clinical Research Professional

Medicines development and clinical research are among the most heavily regulated activities on a global basis.


Natasha Blakeney, MPH

Latest:

Making a Difference in Cancer Trials Accrual

The integration of pre-screening all patients for eligibility in oncology studies.


CluePoints

Latest:

Case Study: Confirmation of Fraud - Diaries Completed by Staff

In a phase III trial in vascular disease, over 4,500 patients were randomized across 160 sites.


Rickie Stevens

Latest:

A Different Approach to CTMS

In order to manage critical clinical trial information, sponsors and CROs typically implement a strict data management structure...


Michael O’Kelly

Latest:

Lifecycle Modeling and Simulation in Clinical Trials

How the application of evolving M&S models are transforming full-research design strategies.


William Curatolo

Latest:

Artisanal Publishing

In my previous blog "From Science to Fiction" (ACTO, April 15, 2014), I discussed the trials and tribulations of unlearning the scientific writing style...


Marie A. Daleo

Latest:

Optimizing Clinical Trial Enrollment Methods Through "Goal Programming"

Clinical trials often fail to reach desired goals due to poor recruitment outcomes, including low participant turnout, high recruitment cost, or poor representation of minorities.


Jorge G. Guerra, MD

Latest:

From Telex to Terabytes: Using Technology to Optimize Clinical Operations

As a principal investigator in the early 1980s at University Hospital in Peru, I used to receive instructions and queries from the study team through a Telex machine.



Ulrich Raeth, MD

Latest:

Cancer Trials: Raising Accrual Rates

Lessons learned from the recruitment of colorectal cander patients into clinical trials.


Kerry Dyson

Latest:

Research in the United Kingdom

The current initiatives and a historical overview of the clinical trial landscape.


Robb Giddings

Latest:

Clinical Contracting Efficiency

A simple but overlooked way to save millions of dollars during new drug development.


Andrew Garrett

Latest:

Lifecycle Modeling and Simulation in Clinical Trials

How the application of evolving M&S models are transforming full-research design strategies.


N. Seth Berry

Latest:

Lifecycle Modeling and Simulation in Clinical Trials

How the application of evolving M&S models are transforming full-research design strategies.


Audrius Sveikata

Latest:

Clinical Trials in the Baltic States

The region has an appropriate population size, solid infrastructure, experienced nvestigators, and short timelines.


Sheila Mikhail

Latest:

Clinical Contracting Efficiency

A simple but overlooked way to save millions of dollars during new drug development.


Mark M. Engelhart

Latest:

Performance Metrics: Optimizing Outcomes

A clearly defined set of performance measures is an integral part of the central laboratory selection and management process.


© 2024 MJH Life Sciences

All rights reserved.